coagulation factor ix (recombinant)

FDA Drug Profile — BeneFIX

coagulation factor ix (recombinant) is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand name including BeneFIX. Available dosage form: kit.

Drug details

Generic Name
coagulation factor ix (recombinant)
Brand Names
BeneFIX
Application Number
BLA103677
Sponsor
Wyeth BioPharma Division Of Wyeth Pharmaceuticals LLC
NDC Codes
5
Dosage Forms
KIT

Indications and Usage

1 INDICATIONS AND USAGE IXINITY, Coagulation Factor IX (Recombinant), is a human blood coagulation factor indicated in adults and children with hemophilia B for: On-demand treatment and control of bleeding episodes Perioperative management Routine prophylaxis to reduce the frequency of bleeding episodes IXINITY is not indicated for induction of immune tolerance in patients with hemophilia B [see Warnings and Precautions ( 5.3 ) ]. IXINITY, Coagulation Factor IX (Recombinant), is a human blood coagulation factor indicated in adults and children with hemophilia B for: On-demand treatment and control of bleeding episodes ( 1 ) Perioperative management ( 1 ) Routine prophylaxis to reduce the frequency of bleeding episodes ( 1 ) IXINITY is not indicated for induction of immune tolerance in patients with hemophilia B. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.